Bempedoic Acid: A New Tool for Diabetes‑Related Cholesterol

The fight against heart disease in people with diabetes is tough. Diabetes often comes with high cholesterol, and that raises the risk of heart attacks. Doctors usually give statins first, but many patients still have too much bad cholesterol. A new medicine called bempedoic acid works differently from statins. It stops an enzyme in the liver that makes cholesterol, so it lowers LDL‑C without hurting muscles. Clinical studies show it cuts LDL‑C, apolipoprotein B and non‑HDL‑C. It also lowers a marker of inflammation called hs‑CRP, which is linked to heart problems.

In a big trial named CLEAR Outcomes, bempedoic acid reduced serious heart events in people who could not take statins. About half of those patients had diabetes, and their blood sugar stayed stable. Because it is taken by mouth, bempedoic acid can reach patients who cannot use more expensive treatments like PCSK9 inhibitors. It helps close the gap for those whose cholesterol remains high even after statins. Doctors in Italy now see it as a useful add‑on when standard therapy falls short. It offers another safe option to lower the chance of heart attacks and strokes in high‑risk diabetes patients.

Actions